ATE267253T1 - Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung - Google Patents

Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung

Info

Publication number
ATE267253T1
ATE267253T1 AT94907948T AT94907948T ATE267253T1 AT E267253 T1 ATE267253 T1 AT E267253T1 AT 94907948 T AT94907948 T AT 94907948T AT 94907948 T AT94907948 T AT 94907948T AT E267253 T1 ATE267253 T1 AT E267253T1
Authority
AT
Austria
Prior art keywords
htlv
peptides derived
diagnostic use
infection
peptides
Prior art date
Application number
AT94907948T
Other languages
English (en)
Inventor
Kenneth G Hadlock
Chin-Joo Goh
Steven K H Fong
Original Assignee
Genelabs Tech Inc
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc, Univ Leland Stanford Junior filed Critical Genelabs Tech Inc
Application granted granted Critical
Publication of ATE267253T1 publication Critical patent/ATE267253T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94907948T 1993-02-05 1994-02-02 Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung ATE267253T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/014,153 US5643714A (en) 1986-12-31 1993-02-05 Method and assay for HTLV
PCT/US1994/001170 WO1994018322A1 (en) 1993-02-05 1994-02-02 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS

Publications (1)

Publication Number Publication Date
ATE267253T1 true ATE267253T1 (de) 2004-06-15

Family

ID=21763838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907948T ATE267253T1 (de) 1993-02-05 1994-02-02 Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung

Country Status (10)

Country Link
US (1) US5643714A (de)
EP (1) EP0682703B1 (de)
JP (1) JP3470899B2 (de)
AT (1) ATE267253T1 (de)
AU (1) AU690540B2 (de)
CA (1) CA2155001C (de)
DE (1) DE69433787T2 (de)
ES (1) ES2221664T3 (de)
SG (1) SG49829A1 (de)
WO (1) WO1994018322A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063160A1 (en) * 2000-10-17 2004-04-01 Lassen Michael Rud Assay for directly detecting a biological cell in a body fluid sample
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
JP2015215244A (ja) * 2014-05-12 2015-12-03 富士レビオ株式会社 免疫測定における抗htlv抗体の検出感度を向上させる方法
CN107356753B (zh) * 2017-07-21 2019-02-05 苏州华益美生物科技有限公司 人t淋巴细胞病毒(htlv)抗体检测试剂盒及其应用和制备
CN116790823B (zh) * 2023-08-17 2023-12-08 中国人民解放军空军特色医学中心 同步检测htlv-1和htlv-2的双重定量rt-pcr检测组合物、试剂盒和方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
JPS58187861A (ja) * 1982-04-26 1983-11-02 Otsuka Pharmaceut Co Ltd 成人型t細胞性白血病関連抗体の測定法
JPS5962527A (ja) * 1982-09-30 1984-04-10 Eisai Co Ltd 成人t細胞白血病関連抗原の製造方法
JPS59104325A (ja) * 1982-12-07 1984-06-16 Japan Found Cancer ヒト白血病ウイルスの遺伝子rnaに相補性を示すdna
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
US4724258A (en) * 1984-02-03 1988-02-09 Juridical Foundation, Japanese Foundation For Cancer Research Adult T cell leukemia virus antigen polypeptide
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
JPS60249058A (ja) * 1984-05-25 1985-12-09 Eisai Co Ltd Atlウイルス抗体の測定方法および試薬
US4731326A (en) * 1984-06-04 1988-03-15 Ortho Diagnostic Systems Inc. Disease diagnosis by detection of shed normal tissue antigens
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
DE3585087D1 (de) * 1984-09-19 1992-02-13 Univ California Retrovirale polypeptide in zusammenhang mit menschlicher transformation.
US4722888A (en) * 1985-03-29 1988-02-02 United States Of America As Represented By The Department Of Health And Human Services Cell line producing human monoclonal antibody which binds to HTLV-I producing cells
US4661445A (en) * 1985-05-24 1987-04-28 Saxinger W Carl Competitive ELISA for the detection of HTLV-III antibodies
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
EP0246101A3 (de) * 1986-05-14 1989-06-07 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Protein mit HTLV-I-antigener Aktivität und dessen Herstellung
JP2501569B2 (ja) * 1986-11-14 1996-05-29 協和醗酵工業株式会社 抗成人t細胞白血病ウイルス抗体の検出法
US5079351A (en) * 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
US5066579A (en) * 1986-12-31 1991-11-19 Genelabs Incorporated HTLV-I peptide antigen and assay
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
US5003043A (en) * 1988-05-25 1991-03-26 Triton Biosciences Inc. Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
EP0345792A3 (de) * 1988-06-10 1991-05-02 F. Hoffmann-La Roche Ag HTLV-1/HIV-1-Fusionsproteine
WO1990015075A1 (en) * 1989-06-01 1990-12-13 E.I. Du Pont De Nemours And Company HTLV-1 ENV GENE PRODUCTS EXPRESSED IN $i(E. COLI)
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
JPH0319789A (ja) * 1989-06-14 1991-01-28 Fanuc Ltd レーザロボットの制御方式
DE69019291T2 (de) * 1989-10-23 1995-09-21 Hoffmann La Roche Synthetische HTLV-I Hüll-Peptide.
IE904083A1 (en) * 1989-11-13 1991-05-22 Cambridge Biotech Corp Diagnostic proteins to test for more than one antibody
WO1991007510A1 (en) * 1989-11-17 1991-05-30 Amgen Inc. A method of detecting htlv-i antibodies in human body fluids

Also Published As

Publication number Publication date
JP3470899B2 (ja) 2003-11-25
DE69433787T2 (de) 2005-05-25
WO1994018322A1 (en) 1994-08-18
AU6132094A (en) 1994-08-29
CA2155001A1 (en) 1994-08-18
EP0682703A1 (de) 1995-11-22
ES2221664T3 (es) 2005-01-01
SG49829A1 (en) 1998-06-15
EP0682703B1 (de) 2004-05-19
AU690540B2 (en) 1998-04-30
DE69433787D1 (de) 2004-06-24
US5643714A (en) 1997-07-01
JPH08509597A (ja) 1996-10-15
CA2155001C (en) 1999-07-20

Similar Documents

Publication Publication Date Title
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
WO1999064592A3 (en) Green fluorescent proteins for measuring the ph of a biological sample
TR200601231T2 (tr) Alzheimer hastalığı sekretazı.
GB9921155D0 (en) Selection system
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
SE8902532L (sv) Bestaemning av plasmaproteiner
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
DE69840445D1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
WO2001044809A3 (fr) Evaluation d'agents biologiques dans des cellules cibles vivantes
DE69433787D1 (de) Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
AU7310994A (en) Corpuscles of stannius protein, stanniocalcin
DE69728897D1 (de) Saeugetierchemokine
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
AU4981093A (en) Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof
DE69028561T2 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE294237T1 (de) S?ugetier thymokingene
WO1996040763A3 (en) Peptides for hiv-1 detection
FR2765688B1 (fr) Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2
WO2000058438A3 (en) Conformationally constrained peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties